✦ LIBER ✦

INITIAL PSA LEVELS AND PROSTATE CANCER DIAGNOSIS WITH UP TO 7 YEARS FOLLOW-UP IN THE PLCO CANCER SCREENING TRIAL

✍ Scribed by Black, Amanda; Grubb, Robert L; Hickey, Thomas; Pinsky, Paul F; Reding, Douglas; Izmirlian, Grant; Mabie, Jerome; Riley, Thomas; Ragard, Lawrence R; Prorok, Philip C; Berg, Christine D; Crawford, E David; Andriole, Gerald L

Book ID: 123010093
Publisher: Lippincott Williams and Wilkins
Year: 2009
Tongue: English
Weight: 74 KB
Volume: 181
Category: Article
ISSN: 0022-5347
DOI: 10.1016/S0022-5347(09)61815-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Prostate Cancer Screening in the Randomi

Prostate Cancer Screening in the Randomized Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial: Mortality Results after 13Years of Follow-up

✍ Andriole, G.L. 📂 Article 📅 2012 🏛 Elsevier Science ⚖ 51 KB

Prostate Cancer Screening in the Randomi

Prostate Cancer Screening in the Randomized Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial: Mortality Results after 13Years of Follow-up

✍ Kibel, A.S. 📂 Article 📅 2012 🏛 Elsevier Science ⚖ 56 KB

Re: Prostate Cancer Screening in the Ran

Re: Prostate Cancer Screening in the Randomized Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial: Mortality Results After 13 Years of Follow-up

✍ Andrew Vickers 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 40 KB

Re: Prostate Cancer Screening in the Ran

Re: Prostate Cancer Screening in the Randomized Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial: Mortality Results after 13 Years of Follow-Up

✍ Walsh, Patrick C. 📂 Article 📅 2012 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 128 KB

PS2 Late breaking Adding bicalutamide 15

PS2 Late breaking Adding bicalutamide 150mg to standard care for localised or locally advanced prostate cancer: results from the largest hormonal therapy trial ever conducted in prostate cancer patients, at over 7 years' follow up

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 54 KB

Survival in prostate carcinoma—Outcomes

Survival in prostate carcinoma—Outcomes from a prospective, population-based cohort of 8887 men with up to 15 years of follow-up : Results from three counties in the population-based National Prostate Cancer Registry of Sweden

✍ Gunnar Aus; David Robinson; Johan Rosell; Gabriel Sandblom; Eberhard Varenhorst 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 153 KB 👁 2 views

## Abstract ## BACKGROUND To decide on screening strategies and curative treatments for prostate carcinoma, it is necessary to determine the incidence and survival in a population that is not screened. ## METHODS The 15‐year projected survival data were analyzed from a prospective, complete, pop